Unique β-Glucuronidase Locus in Gut Microbiomes of Crohn’s Disease Patients and Unaffected First-Degree Relatives

Overweight and obesity in children with newly diagnosed inflammatory bowel disease

(2016) Aleksandra Pituch-Zdanowska et al.   Advances in Medical Sciences

Measures of Obesity and Risk of Crohnʼs Disease and Ulcerative Colitis

(2015) Hamed Khalili et al.   INFLAMMATORY BOWEL DISEASES

Contribution ofMDR1gene polymorphisms on IBD predisposition and response to glucocorticoids in IBD in a Chinese population

(2015) Qing Fan Yang et al.   Journal of Digestive Diseases

Genetic studies of Crohn's disease: Past, present and future

(2014) Jimmy Z. Liu et al.   BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY

The Treatment-Naive Microbiome in New-Onset Crohn’s Disease

(2014) Dirk Gevers et al.   Cell Host & Microbe

Body Mass Index and the Risk for Crohn's Disease and Ulcerative Colitis: Data From a European Prospective Cohort Study (The IBD in EPIC Study)

(2013) Simon S M Chan et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Increased antibody response to microbial antigens in patients with Crohn's disease and their unaffected first-degree relatives

(2013) Andrea Michielan et al.   DIGESTIVE AND LIVER DISEASE

Geographical variability and environmental risk factors in inflammatory bowel disease

(2013) Siew C Ng et al.   GUT

Altered Gut Microbiota Promotes Colitis-Associated Cancer in IL-1 Receptor–Associated Kinase M–Deficient Mice

(2013) Klara Klimesova et al.   INFLAMMATORY BOWEL DISEASES

Disarming Bacterial Virulence through Chemical Inhibition of the DNA Binding Domain of an AraC-like Transcriptional Activator Protein

(2013) Ji Yang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Richness of human gut microbiome correlates with metabolic markers

(2013) Emmanuelle Le Chatelier et al.   NATURE

Pharmacogenomics Knowledge for Personalized Medicine

(2012) M Whirl-Carrillo et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Gut inflammation can boost horizontal gene transfer between pathogenic and commensal Enterobacteriaceae

(2012) B. Stecher et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Cultured Representatives of Two Major Phylogroups of Human Colonic Faecalibacterium prausnitzii Can Utilize Pectin, Uronic Acids, and Host-Derived Substrates for Growth

(2011) Mireia Lopez-Siles et al.   APPLIED AND ENVIRONMENTAL MICROBIOLOGY

Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives

(2011) M. Joossens et al.   GUT

Enterotypes of the human gut microbiome

(2011) Manimozhiyan Arumugam et al.   NATURE

The role of bacteria and pattern-recognition receptors in Crohn's disease

(2011) Si Ming Man et al.   Nature Reviews Gastroenterology & Hepatology

Control of bacterial virulence by AraC-like regulators that respond to chemical signals

(2011) Ji Yang et al.   TRENDS IN MICROBIOLOGY

Biodegradation of estrogen conjugates by bacteria isolated from river sediments

(2011) C. N. Duong et al.   WATER SCIENCE AND TECHNOLOGY

Glucuronidation Genotypes and Nicotine Metabolic Phenotypes: Importance of Functional UGT2B10 and UGT2B17 Polymorphisms

(2010) G. Chen et al.   CANCER RESEARCH

Is the abundance of Faecalibacterium prausnitzii relevant to Crohn's disease?

(2010) Wenjing Jia et al.   FEMS MICROBIOLOGY LETTERS

A human gut microbial gene catalogue established by metagenomic sequencing

(2010) Junjie Qin et al.   NATURE

Estimation of effect size distribution from genome-wide association studies and implications for future discoveries

(2010) Ju-Hyun Park et al.   NATURE GENETICS

A metagenomic  -glucuronidase uncovers a core adaptive function of the human intestinal microbiome

(2010) K. Gloux et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Alleviating Cancer Drug Toxicity by Inhibiting a Bacterial Enzyme

(2010) B. D. Wallace et al.   SCIENCE

Targeting Bacteria to Improve Cancer Therapy

(2010) A. G. Patel et al.   SCIENCE

Low counts of Faecalibacterium prausnitzii in colitis microbiota

(2009) H. Sokol et al.   INFLAMMATORY BOWEL DISEASES

Stable expression of Escherichia coli  -glucuronidase A (GusA) in Giardia lamblia: application to high-throughput drug susceptibility testing

(2009) J. Muller et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Inference and Characterization of Horizontally Transferred Gene Families Using Stochastic Mapping

(2009) O. Cohen et al.   MOLECULAR BIOLOGY AND EVOLUTION

Metabolomics Reveals Metabolic Biomarkers of Crohn's Disease

(2009) Janet Jansson et al.   PLoS One

Role of gut microbiota in Crohn’s disease

(2009) Phillip I Baker et al.   Expert Review of Gastroenterology & Hepatology

Cancer risks in Crohn disease patients

(2008) K. Hemminki et al.   ANNALS OF ONCOLOGY

Microbial Influences in Inflammatory Bowel Diseases

(2008) R. Balfour Sartor   GASTROENTEROLOGY

Twin studies reveal specific imbalances in the mucosa-associated microbiota of patients with ileal Crohnʼs disease

(2008) Ben Willing et al.   INFLAMMATORY BOWEL DISEASES

Up-regulation and Cytoprotective Role of Epithelial Multidrug Resistance-associated Protein 1 in Inflammatory Bowel Disease

(2008) Hans Blokzijl et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease

(2008) Jeffrey C Barrett et al.   NATURE GENETICS

Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients

(2008) H. Sokol et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

ABC multidrug transporters: structure, function and role in chemoresistance

(2007) Frances J Sharom   PHARMACOGENOMICS